{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:41Z","timestamp":1790334821476,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/bjd.14547","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:54:54Z","timestamp":1458348894000},"page":"464-472","source":"Crossref","is-referenced-by-count":72,"title":["Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies"],"prefix":"10.1093","volume":"175","author":[{"given":"R.","family":"Bobotsis","sequence":"first","affiliation":[{"name":"Schulich School of Medicine; Western University; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.","family":"Gulliver","sequence":"additional","affiliation":[{"name":"Department of Medicine; Faculty of Medicine; Memorial University of Newfoundland; St. John's NF Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Monaghan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine (Obstetrics); Faculty of Medicine; Memorial University of Newfoundland; St. John's NF Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lynde","sequence":"additional","affiliation":[{"name":"Lynde Dermatology (Private Practice); Markham ON Canada"},{"name":"Division of Dermatology; University of Toronto; Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Division of Dermatology; University of Toronto; Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,24]]},"reference":[{"key":"10.1111\/bjd.14547-BIB0001|bjd14547-cit-0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/dth.12073","article-title":"Management of psoriasis in pregnancy","volume":"26","author":"Babalola","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.14547-BIB0002|bjd14547-cit-0002","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1111\/bjd.14547-BIB0003|bjd14547-cit-0003","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14547-BIB0004|bjd14547-cit-0004","first-page":"1","article-title":"Psoriasis and the pregnant woman: what are the key considerations?","volume":"16","author":"Landau","year":"2011","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/bjd.14547-BIB0005|bjd14547-cit-0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1111\/bjd.14547-BIB0006|bjd14547-cit-0006","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ad.2013.06.004","article-title":"Psoriasis in pregnancy: a review","volume":"105","author":"Ruiz","year":"2014","journal-title":"Actas Dermoifiliogr"},{"key":"10.1111\/bjd.14547-BIB0007|bjd14547-cit-0007","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.jid.5700118","article-title":"Distinct clinical difference between HLA-Cw*0602 positive and negative psoriasis patients - an analysis of 1019 HLA-C and HLA-B-typed patients","volume":"126","author":"Gudjonsson","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14547-BIB0008|bjd14547-cit-0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jid.2011.271","article-title":"The impact of psoriasis on pregnancy outcomes","volume":"132","author":"Lima","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14547-BIB0009|bjd14547-cit-0009","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-3083.2010.03917.x","article-title":"Pregnancy outcomes in women with moderate-to-severe psoriasis","volume":"25","author":"Cohen-Barak","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14547-BIB0010|bjd14547-cit-0010","first-page":"183","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Ben-David","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1111\/bjd.14547-BIB0011|bjd14547-cit-0011","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/jid.2014.35","article-title":"No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis","volume":"124","author":"Harder","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14547-BIB0012|bjd14547-cit-0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2010.02.005","article-title":"Psoriasis and pregnancy outcomes: a nationwide population-based study","volume":"64","author":"Yang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14547-BIB0013|bjd14547-cit-0013","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/bjd.14547-BIB0014|bjd14547-cit-0014","unstructured":"U.S. Preventive Services Task Force U.S. Preventive Services Task Force Quality Rating Criteria http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK47515\/"},{"key":"10.1111\/bjd.14547-BIB0015|bjd14547-cit-0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000096910","article-title":"Pregnancy and pregnancy outcome among women with inflammatory skin diseases","volume":"214","author":"Seeger","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/bjd.14547-BIB0016|bjd14547-cit-0016","first-page":"AB179","article-title":"Pregnancy outcomes in women with dermatologic conditions exposed to infliximab","author":"Yurkon","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14547-BIB0017|bjd14547-cit-0017","first-page":"AB178","article-title":"Pregnancy outcomes in women exposed to ustekinumab in the psoriasis clinical development program","author":"Schaufelberg","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14547-BIB0018|bjd14547-cit-0018","first-page":"AB179","article-title":"Pregnancy outcomes in women with moderate to severe psoriasis: the PSOLAR experience","author":"Kimball","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14547-BIB0019|bjd14547-cit-0019","unstructured":"Public Health Agency of Canada Congenital anomalies in Canada 2013: a perinatal health surveillance report http:\/\/publications.gc.ca\/collections\/collection_2014\/aspc-phac\/HP35-40-2013-eng.pdf"},{"key":"10.1111\/bjd.14547-BIB0020|bjd14547-cit-0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"57","author":"Cornish","year":"2007","journal-title":"Gut"},{"key":"10.1111\/bjd.14547-BIB0021|bjd14547-cit-0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.2010.02239.x","article-title":"Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study","volume":"268","author":"Norgaard","year":"2010","journal-title":"J Intern Med"},{"key":"10.1111\/bjd.14547-BIB0022|bjd14547-cit-0022","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.39202.518484.80","article-title":"Management of psoriasis in pregnancy","volume":"334","author":"Weatherhead","year":"2007","journal-title":"BMJ"},{"issue":"Suppl.","key":"10.1111\/bjd.14547-BIB0023|bjd14547-cit-0023","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ddr.21199","article-title":"A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis","volume":"75","author":"De Simone","year":"2014","journal-title":"Drug Dev Res"},{"key":"10.1111\/bjd.14547-BIB0024|bjd14547-cit-0024","first-page":"211","article-title":"Somatic and non-somatic problems connected with psoriasis in pregnancy","volume":"84","author":"Studzinska","year":"2013","journal-title":"Ginekol Pol"},{"key":"10.1111\/bjd.14547-BIB0025|bjd14547-cit-0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-Cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/bjd.14547-BIB0026|bjd14547-cit-0026","doi-asserted-by":"crossref","first-page":"401e1","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14547-BIB0027|bjd14547-cit-0027","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","volume":"10","author":"Chi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.14547-BIB0028|bjd14547-cit-0028","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv234","article-title":"Anti-tumour necrosis factor a therapies and inflammatory bowel disease pregnancy outcomes: a meta-analysis","author":"Shihab","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1111\/bjd.14547-BIB0029|bjd14547-cit-0029","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","article-title":"Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis","volume":"163","author":"Bandoli","year":"2010","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14547","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14547","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14547\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:19:44Z","timestamp":1676384384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/3\/464\/6617002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,24]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14547","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,24]]}}}